List of Ribomic patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11639503 Anti-chymase aptamer and use for same	Patent 11639503 was granted and assigned to Ribomic on May, 2023 by the United States Patent and Trademark Office.	Ribomic	Ribomic	United States Patent and Trademark Office	11639503	May 2, 2023
‌ US Patent 8716230 Methods for treatment or prevention of diseases associated with functional disorder of regulatory T cells	Patent 8716230 was granted and assigned to Ribomic on May, 2014 by the United States Patent and Trademark Office.		Ribomic	United States Patent and Trademark Office	8716230	May 6, 2014
‌ US Patent 8637656 Nucleic acid capable of binding to immunoglobulin G and use thereof	Patent 8637656 was granted and assigned to Ribomic on January, 2014 by the United States Patent and Trademark Office.		Ribomic	United States Patent and Trademark Office	8637656	January 28, 2014
‌ US Patent 9987298 Aptamer for FGF2 and use thereof	Patent 9987298 was granted and assigned to Ribomic on June, 2018 by the United States Patent and Trademark Office.	Ribomic	Ribomic	United States Patent and Trademark Office	9987298	June 5, 2018
‌ US Patent 8772259 Aptamer to FGF2 and use thereof	Patent 8772259 was granted and assigned to Ribomic on July, 2014 by the United States Patent and Trademark Office.		Ribomic	United States Patent and Trademark Office	8772259	July 8, 2014
‌ US Patent 8080649 Aptamer against midkine and use thereof	Patent 8080649 was granted and assigned to Ribomic on December, 2011 by the United States Patent and Trademark Office.		Ribomic	United States Patent and Trademark Office	8080649	December 20, 2011
‌ US Patent 11473089 Aptamer for ADAMTS5 and use for aptamer for ADAMTS5		Ribomic	Ribomic	United States Patent and Trademark Office	11473089	October 18, 2022